Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Balance Ophthalmics is a clinical-stage medical technology company focused on developing non-invasive treatments for glaucoma and other ophthalmic conditions. The company's flagship technology, the Multi-Pressure Dial (MPD), consists of a specialized pair of goggles that creates a localized atmospheric pressure environment around the eye to modulate the translaminar pressure gradient. This innovative approach aims to reduce optic nerve strain and lower intraocular pressure without the need for invasive surgery or chronic pharmaceutical use. Balance Ophthalmics is currently advancing its lead program through pivotal clinical trials to provide a new therapeutic option for patients with various forms of glaucoma, including those with normal-tension glaucoma.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Balance Ophthalmics.